ETCIA yields 666666.67% · PFE yields 6.13%● Live data
📍 ETCIA pulled ahead of the other in Year 1
Combined, ETCIA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ETCIA + PFE for your $10,000?
Electronic Tele-Communications, Inc. designs, manufactures, markets, leases, and sells digital voice information systems and related services to the telecommunications industry and other businesses. Its equipment provides a range of audio and computer information, and call handling capabilities through telephone networks, computer networks, and the Internet. The company's digital voice information systems deliver network interoperability, as well as applications, including branding, time and temperature announcements, weather forecasts, automatic callback, changed number with call completion, repeat dialing, and wake-up/reminder services. It offers Digicept Emcee ELF3 and Digicept Emcee ELF that provide applications and services in a single platform for circuit and packet-switched networks; Audichron Z-10, a time-temperature-weather announcer; Audichron Z-10 MCA, a multi-channel announcer; digital announcement systems; professional recording services; weathertel forecasting services; and MAX Terminator, which offers disconnect detection to eliminate tied-up lines and annoying tones. The company also provides installation, repair, maintenance, and weather update services, as well as professional recording of announcements; turn-key installations; and on-site training and technical support services. It serves regional bell operating companies, competitive local exchange carriers, independent telephone companies, long distance companies, wireless carriers, cable companies, telecommunications manufacturers, utilities, and other businesses and organizations. The company was incorporated in 1980 and is based in Waukesha, Wisconsin.
Full ETCIA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.